Product Center Product Center
Your current location:
Homepage
>
>
>
Clopidogrel Bisulfate

Clopidogrel Bisulfate

The company always adheres to the business purpose of "creating eternity for health" and is committed to the development of the pharmaceutical industry Founded in 2001, it is located in the Jiaojiang Block of the Chemical Raw Material Medicine Industrial Park in Taizhou, Zhejiang. The company occupies an area of ​​nearly 300 acres and is a core subsidiary of Lepu (Beijing) Medical Equipment Co., Ltd. (stock code 300003), under its jurisdiction Lepu Pharmaceutical Technology Co., Ltd. and Zhejiang Lepu Pharmaceutical Import and Export Co., Ltd. Mainly engaged in the research and development, production and sales of cardiovascular, anti-infective, anti-tumor and nervous system drugs. The main products are atorvastatin calcium, rosuvastatin calcium, norfloxacin and other raw materials and preparations. The company attaches great importance to product quality, and has successively passed GMP certifications and registrations such as China NM-PA, US FDA, EU EDQM, Japan PMDA and South Korea KFDA. Many varieties have a leading position in the world.
Category:
Devolop product
Market price
0.0
Retail price
0.0
Number of views:
1000
Online Inquiry E-mail: ttxsss@qq.cn
Quantity
-
+
Stock:
0
暂时无货
1
Clinical application:
Antithrombotic/platelet aggregation inhibitor
Certification:

in-house

Clinical application:
Antithrombotic/platelet aggregation inhibitor
Certification:

in-house

Founded in 2001, it is located in the Jiaojiang Block of the Chemical Raw Material Medicine Industrial Park in Taizhou, Zhejiang. The company occupies an area of ​​nearly 300 acres and is a core subsidiary of Lepu (Beijing) Medical Equipment Co., Ltd. (stock code 300003), under its jurisdiction Lepu Pharmaceutical Technology Co., Ltd. and Zhejiang Lepu Pharmaceutical Import and Export Co., Ltd. Mainly engaged in the research and development, production and sales of cardiovascular, anti-infective, anti-tumor and nervous system drugs. The main products are atorvastatin calcium, rosuvastatin calcium, norfloxacin and other raw materials and preparations. The company attaches great importance to product quality, and has successively passed GMP certifications and registrations such as China NM-PA, US FDA, EU EDQM, Japan PMDA and South Korea KFDA. Many varieties have a leading position in the world. The company is a national high-tech enterprise, the first batch of demonstration units for the transfer and transformation of national scientific and technological achievements, and a boutique manufacturing enterprise in Zhejiang. It has built a national academician workstation, a postdoctoral workstation and a provincial research institute, and has strong research and development capabilities. It has established laboratories jointly with famous domestic universities and research institutes such as Zhejiang University, Nankai University, and Shanghai Medical Engineering Institute, and hired a group of professors and industry experts to serve as R&D guidance, building a bridge between industrial capital and intellectual capital. In recent years, more than 40 invention patents have been authorized, and more than 50 new products have been developed. Among them, the "Atorvastatin Calcium Chemistry-Enzymatic Synthesis Key Technology and Industrialization" project won the first prize of Zhejiang Science and Technology Progress Award. Atorvastatin calcium tablets passed the quality consistency evaluation and won the bid for collection. The company has extensive cooperation with many large international companies to increase the research and development of new drugs and provide lasting impetus for the medium and long-term development of the company. The company’s marketing network covers five continents, and has established partnerships with more than 600 domestic and foreign customers in more than 70 countries and regions. Many products are leading the sales in the international market. The sales of the main variety of atorvastatin calcium account for 50% of the world’s total. %the above. Looking forward to the future, the company focuses on the development of solid preparations and APIs, and builds a multi-functional incubation platform for APIs and preparations to create a good situation in which APIs, preparations, and CMO "troika" go hand in hand.

img  img  img

 

 

The company always adheres to the business purpose of "creating eternity for health" and is committed to the development of the pharmaceutical industry. Adhering to the entrepreneurial spirit of "Unity in a city, leaping over infinite" has formed an organizational atmosphere of innovation and change. At the same time, it advocates the concept of "people-oriented, teamwork", through scientific organization setting, professional job design, standardization of work flow, daily knowledge training, stimulate the potential of employees, maximize value creation, and provide a leapfrog development for the company A strong guarantee; to achieve the company's strategic goals with collective wisdom and strength, a young team has been formed that is striving, hardworking, daring to meet new challenges, and energetic.

In the face of new opportunities and challenges, the company will continue to follow the business philosophy of "management as the business and innovation as the latitude", fully carry forward the team spirit, comprehensively enhance the corporate culture, work hard, pioneer and innovate, and make a contribution to the development of the pharmaceutical industry. Greater contribution.

Keyword:
API
Domestic preparations
Devolop product
Intermediate

Related Products

    • Product name
    • Clinical application
    • Certification
    • Clopidogrel Bisulfate
    • Clinical application Antithrombotic/platelet aggregation inhibitor
    • Certification in-house
    • LCZ696
    • Clinical application Heart failure
    • Certification in-house
    • Atorvastatin Calcium
    • Clinical application Antihyperlipidem
    • Certification DMF No.26022,CEP 2012-139,US-FDA,GMP/WC
    • Rosuvastatin Calcium
    • Clinical application Antihyperlipidemia
    • Certification DMF No.25781、 US-FDA、 ASMF、 WC
    • Norfloxacin Base
    • Clinical application Antibiotics
    • Certification GMP、DMF、 CEP2006-037
    • Linezolid
    • Clinical application Antibiotics
    • Certification DMF NO.26962、ASMF
    • Doxazosin Mesylate
    • Clinical application Hypertension & Prostate hyperphasia
    • Certification GMP、DMF
  • 上一页
    1

    Online Inquiry

    Username used for comment:
    Client Messages
    Description:
    这是描述信息

    Support Hotline

    QR code

    Scan to enter

    Copyright © 2021 Zhejiang LePu Pharmaceutical Co., Ltd. All rights reserved 浙ICP备17026965号 Powered by www.300.cn